271 related articles for article (PubMed ID: 19526965)
21. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
22. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
23. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
Taéron C
Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
[No Abstract] [Full Text] [Related]
24. Antiviral therapy for chronic hepatitis B: are we doing any good to patients?
Wong VW; Sung JJ
J Antimicrob Chemother; 2009 Aug; 64(2):223-6. PubMed ID: 19468026
[TBL] [Abstract][Full Text] [Related]
25. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
[No Abstract] [Full Text] [Related]
26. Hepatitis B virus viral load and treatment decision.
Tillmann H; Patel K; McHutchison J
Hepatology; 2009 Feb; 49(2):699; author reply 701-2. PubMed ID: 19177581
[No Abstract] [Full Text] [Related]
27. Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.
Liu T; Zhang C; Wang Y
Hepatology; 2011 Aug; 54(2):747-8. PubMed ID: 21360719
[No Abstract] [Full Text] [Related]
28. [Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment].
Ebinuma H; Saito H
Nihon Rinsho; 2011 May; 69 Suppl 4():540-5. PubMed ID: 22096977
[No Abstract] [Full Text] [Related]
29. Tenofovir helps beat hepatitis B.
TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
[No Abstract] [Full Text] [Related]
30. Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
Matthews GV; Dore GJ
AIDS; 2007 Mar; 21(6):777-8. PubMed ID: 17413705
[No Abstract] [Full Text] [Related]
31. [New option for successful therapy of chronic hepatitis B].
Ortleb J
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1565. PubMed ID: 12899163
[No Abstract] [Full Text] [Related]
32. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
Warner N; Locarnini S
Antivir Ther; 2009; 14(2):139-42. PubMed ID: 19430088
[No Abstract] [Full Text] [Related]
33. Managing hepatitis B to prevent liver cancer: recent advances.
Strasser SI
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):409-15. PubMed ID: 24580046
[TBL] [Abstract][Full Text] [Related]
34. Analogs and fibrosis regression in hepatitis B.
Akarca US
Gastroenterol Clin Biol; 2010; 34(6-7):419. PubMed ID: 20452158
[No Abstract] [Full Text] [Related]
35. Use of tenofovir.
AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892609
[No Abstract] [Full Text] [Related]
36. Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.
Sherman M
Cleve Clin J Med; 2009 May; 76 Suppl 3():S6-9. PubMed ID: 19465708
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
[No Abstract] [Full Text] [Related]
38. Tenofovir in chronic hepatitis B.
Del Poggio P; Jamoletti C; Zaccanelli M
Hepatology; 2005 May; 41(5):1199-200; author reply 1200. PubMed ID: 15841450
[No Abstract] [Full Text] [Related]
39. Prevention of hepatocellular carcinoma.
Wands JR
N Engl J Med; 2004 Oct; 351(15):1567-70. PubMed ID: 15470221
[No Abstract] [Full Text] [Related]
40. Emerging therapies of hepatitis B and C.
Chen RY; Desmond PV; Locarnini SA
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S471-81. PubMed ID: 12534781
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]